Introduction
Every mammalian cell is coated by ag lycocalyx, which consists of am ultitude of glycansl inked to proteins or lipids embedded in the cell surface. Glycans are potent regulators of numerous cellular functions. Interference with lipid glycosylation or incorrect N-o rO-linked glycosylation of proteins resultsi nd evelopmental defects and foetal loss. [1] The negatively charged nine-carbon sugar sialic acid (Sia) forms at erminal saccharide in most surface-expressed and soluble glycoconjugates. Biosynthesis of Sia starts in the cytosol and is driven by the bifunctional enzymeU DP-N-acetylglucosamine (UDP-GlcNAc) 2-epimerase/N-acetylmannosamine (ManNAc) kinase (gene: Gne), which catalyses the epimerisation and subsequent phosphorylation of UDP-GlcNAct oM anNAc-6-P( Scheme 1). Neu5Ac-9-phosphate synthase metabolises ManNAc-6-P andp hosphoenolpyruvate (PEP) to N-acetylneuraminic acid (Neu5Ac)-9-phosphate, which is dephosphorylatedt ot he free monosaccharide Neu5AcbyN eu5Ac-9-phosphate phosphatase.
Activation of Neu5Act oi ts cytidine-monophosphated iester is catalysed by the nuclear-locatedC MP-Sia synthase (CMAS, The negatively chargedn onulose sialic acid (Sia) is essential for murined evelopment in vivo. In order to elucidate the impact of sialylation on differentiation processes in the absence of maternal influences, we generated mouse embryonic stem cell (mESC)l ines that lack CMP-Sia synthetase (CMAS) and thereby the ability to activate Sia to CMP-Sia. Loss of CMAS activity resulted in an asialoc ell surface accompanied by an increase in glycoconjugates with terminal galactosyl and oligo-LacNAc residues, as well as intracellular accumulation of free Sia. Remarkably,t hesec hanges did not impact intracellular metabolites or the morphologya nd transcriptome of pluripotent mESC lines. Moreover, the capacity of Cmas À/À mESCs for undirected differentiationi nto embryoid bodies, germ layer formation and even the generation of beating cardiomyocytes provides first and conclusive evidence that pluripotency and differentiation of mESC in vitro can proceed in the absence of (poly)sialoglycans. E.C. 2.7.7.43). CMP-Neu5Ac is transported into the Golgi apparatus by the CMP-Sia transporter (gene: Slc35a1), where Sia is transferred onto nascent glycoconjugates by sialyltransferases in a2,3-or a2,6-linkage onto glycans terminated with either galactose (Gal) or N-acetylgalactosamine (GalNAc), or in a2,8-linkage to terminal Sia. Furthermore,p olysialyltransferases can build Sia homopolymers in a2,8-linkage (polySia)o nto sialyl residues.I na ddition to its function as donor sugar,C MP-Sia also servesa safeedback inhibitor for GNE and thus regulates de novo biosynthesis of Sia. [2] At the cell surface Sia can serve as ar eceptor recognised by ligandss uch as lectins,b ut it can also mask underlying structures to impede the binding of, for example, Gal-specific receptors. [3] Aberrant sialylation has been associated with renal failure, [4] myopathies, [5] auto-immune diseases [6] and metastasis of cancer. [7] Most importantly,m ammalian development strictly depends on the integrity of the sialylation pathway.B locking Sia de novo biosynthesis (e.g.,m ouse Gne knockout) is lethal aroundm idgestation( E10), [8] and interfering with 9-O-acetylation of Sia arrests embryonicd evelopment at the two-cell stage. [9] Despite its great influence on mammalian embryogenesis, the mechanismsb yw hich Sia impedes embryonic development are still unclear.
Embryonic stem cells (ESCs) are useful to address in vitro the mechanisms of intrinsic early embryonic differentiation. ESCs can be obtained either from blastocysts [10] or as induced pluripotent cells (iPSCs) from reprogrammed somatic cells. [11] They can be differentiated in vitro into embryoid bodies (EBs), which reflect formation and development of the early embryo. Only af ew studies have addressed the impact of sialylation on ESC biology, and different observations have been made between human and mouseE SCs. In human ESC lines hyposialylation inducedb yk nockdown of ST6GAL1 (a2,6-sialyltransferase) led to alterations in cellular pluripotencya nd impeded reprogramming of somatic cells; [12] however,h yposialylation in murine ESC (mESC) followingl oss of GNE activity did not impact pluripotency. [13] Nevertheless, in the latter,a lterations in the expression of differentiation markers in Gne-knockout mESCs uggested ar ole for sialylation in differentiation. [14] In these studies, either only a2,6-Sia or the entire cell-surface sialylation was reduced, thus possibly accounting for the divergent results. We therefore sought to analyse mESC development upon complete loss of sialylation. As CMP-Sia is the donor substrate for all sialyltransferases, we interfered with CMP-Sia biosynthesis by genetica blation of CMAS in murinemESCs, and we demonstrated that the early steps in murine embryonic development in vitro proceed independently froms ialoglycoconjugates.
Results

Generation and biochemical characterisation of CMASdeficientmurine ESC
Genetic inactivation of Cmas in murine blastocystsw as accomplished by excision of exon 4, which encodes residues essential for enzymatic activity ( Figure 1A ), [15] followed by confirmation of homologous integration ( Figure 1B ). We used blastocysts 3.5 days after fertilisation (E3.5) from two heterozygous (Cmas + /À )m atings to independently generate three wild-type (WT, Cmas + / + ), eight heterozygous( Cmas + /À )a nd four homozygous (Cmas À/À )m ESC lines (genotyping described in Figure S1 in the Supporting Information). In order to confirms uccessfuli nterference of Cmas expression, mRNA levels were monitored by quantitative PCR (qPCR, Figure 1C ). The expression of Cmas mRNA in Cmas + /À mESCs was clearlyr educed compared to WT mESCs; in Cmas À/À mESCs,n oCmas mRNA signal was obtained (Figure1C). Consistently,CMAS protein expression was reduced in Cmas + /À and absenti nCmas À/À mESCs, thusi ndicating successful genetic inactivation (Figure 1D) . When cultured on murine embryonic fibroblasts, the morphologyo fCmas À/À mESC was indistinguishable from that of WT or Cmas + /À ,w ith characteristic round stem-cell colonies ( Figure 1E ). Indirect immunofluorescence staining of the key pluripotency octamer binding transcription factor3/4 (Oct3/4, also known as Pou5f1) was performed to verify the mESC identity of the isolated cell lines. Oct3/4 was expressed with nuclear localisation in WT and in heterozygous and homozygous mutants( Figure1F). In order to evaluatei fg enetica blation of CMAS affects pluripotency at the transcriptional level, expression of the pluripotency-sustaining factorsO ct3/4, SRY (sexdetermining regionY )-box 2( Sox2), and homeobox protein Nanogw as investigated by qPCR. No significant genotypedependentd ifferences were observed( Figure S2 ). Thus, we successfully generated pluripotent WT and hetero-and homozygous CMAS-deficient mESC lines.
Geneticablation of CMAS results in complete loss of cellsurfaces ialylation with concomitant increase in LacNAc structures
Although there are some convincing arguments (and cell models) to support the hypothesis that CMAS is the only enzyme producing activated Sia as the donor sugar for sialyltransferases, ad efinitive proof has not been provided. With the new cell models we addressed this question by comparing cell-surface sialylation of the isolated pluripotent mESC lines. Glycolipids were addressed by direct immunofluorescence analysiso ft he monosialotetrahexosylganglioside GM1 with FITC-conjugated cholera toxin subunit B( CTXB;F igure 2A). CTXB specifically binds to GM1 with higha ffinity,b ut does not recognise the asialo counterpart GA1. [16] Binding of FITC-conjugated CTXBw as observed in WT and Cmas + /À mESC lines with as imilar pattern,h owever, Cmas À/À mESCsd id not show CTXB reactivity,t hus revealing loss of the sialylated a-series ganglioside GM1 (Figure 2A ).
Protein sialylation in mESC lines wasinvestigated by western blottinga nd lectin analysis( Figure 2B ). Te rminal a2,3-linked Sia residues in WT and Cmas + /À mESClysates stainedwith Maackia amurensis lectin (MAA) showed as imilar pattern with similar intensity.R emoval of terminal Sia by pretreatment with neuraminidase (Neu) abolished these signals and exposed the common penultimate disaccharideg alactose-b1,3-N-acetylgalactosamine, which is recognised by peanuta gglutinin (PNA).
In contrast, homozygous Cmas À/À mESCs were not stainedb y the Sia-specific lectin MAA;h owever,i ncreased PNA reactivity withoutp retreatment and equal reactivity with PNA before and after Neu treatment indicated increased asialo-glycoproteins on the cell surface. Furthermore, polySia (a furtheri ndicator of surface sialylation) was only detected in differentiated WT mESCs and in control lysates of Chinese hamster ovary (CHO) cells, but not in the Cmas À/À mESC lines ( Figure 2C,D ) . Specificity of the polySia signal was controlled by endoneuraminidaseN F( endoNF) treatment.
In order to confirm the asialo phenotype and to monitor global alterations of cell-surface glycosylation, the N-glycome was investigated by high performance multiplexed capillary gel electrophoresis with laser-inducedf luorescenced etection (xCGE-LIF). [17, 18] Thish ighly sensitive methoda llows detecting minor changes in the overall N-glycosylation pattern. The identity of N-glycans wasverified by comprehensive exoglycosidase treatment and annotated according to our internal N-glycan database( Figure S3 A) . Identical N-glycosylation patterns were observedi nW Tand Cmas + /À mESC lines, thus indicatings ialylation at wild-type level despite reduced Cmas expression in Cmas + /À mESCs ( Figure S3 B) . In contrast, a2,3-and a2,6-sialylated N-glycans were absent in Cmas À/À mESCs( 1-6 in Figure 3A) , and sialidase treatment did not result in any change of the electropherogram of Cmas À/À mESC ( Figure 3B ), thus supporting that Cmas À/À mESC are not able to sialylate glycans. Concurrently with the loss of sialylated N-glycans in Cmas À/À mESCs, the signal intensities of N-glycans capped with galactose increased ( Figure 3A ,p eaks 7-10),a nd oligo-LacNAc bearing glycansappeared ( Figure 3C,1 1-15) .
Ta ken together,o ur data show that activation of Sia to CMPSia exclusively relies on CMAS andi sc rucial for the biosynthesis of sialylated glycoconjugates. Furthermore, ablation of CMAS alters the mESCg lycome by replacing usually sialylated N-glycans with galactose and oligo-LacNAc-capped structures. As heterozygous( Cmas + /À )m ESCs show aW Ts ialylation pattern we focused next on WT and Cmas À/À mESC lines. In order to analyse the consequences of Cmas knockout on intracellular metabolite concentration, we first quantified Sia levels by labelling with 1,2-diamino-4,5-methylenedioxy-benzene (DMB) and HPLC analysis. [19] Different Sia derivatives, for example Neu5Ac, 5-N-glycolylneuraminic acid (Neu5Gc) and 5-N-acetyl-9-O-acetylneuraminic acid, were used as standards ( Figure 4A ,t op). Neu5Ac appeared as the predominant Sia derivativei np luripotent WT and in Cmas À/À mESCs ( Figure 4A , bottom,d otted line). As expected, Cmas À/À mESCse xhibited substantial cytosolica ccumulationo fN eu5Ac ( Figure 4A , bottom,s olid line). Peak quantification revealed an almost3 0-fold increasec ompared to WT ( Figure 4B ). In order to confirm this metabolic effect in as econd model we tested WT and CMAS À/À human embryonic kidney (HEK 293) cells ( Figure 4C ): there wase ven greater accumulation (200-fold increaseo fi ntracellularN eu5Ac). Although the absolute size of the Sia pool in the cytosol might be cell type-or species-specific, our data are in perfect agreement with the described regulatory function of CMP-Sia in de novo biosynthesis.
Notably,t he Sia accumulation in our Cmas À/À cell lines is highly reminiscent of what has been describedi ns ialuria patients, ac linical consequence of Gne mutationst hat prevent feedback inhibition by CMP-Sia. Because sialuriap atients excrete Neu5Aci nh igh concentration (up to 15 000 mmol per mmol creatinine;n ormal < 74 mmol mmol À1 ), [20] we analysed if Cmas À/À mESCs release Siai nto the cell-culture medium. After two days of cultivation, samples were taken from WT and knockout cells, and Sia concentrationsw ere compared to that in fresh medium. To our surprise, there was no significant differencei nS ia releaseb etween mutant and WT cells, either in ESCs ( Figure 4D )o rH EK 293 cells ( Figure 4E ). Remarkably,i ndependento fH EK 293 genotype, these cells deprived Sia from the medium, ane ffect that needs furtherinvestigation.
Intracellular Neu5Ac accumulationalters neither associated metabolites nor intracellular glycosylation
Because of the massively elevated cytosolic Neu5Ac concentrations in Cmas-knockout cells, we assumed that other metabolites and/orp athways would also be changed( Figure 5A ). Neu5Ac can be catabolised to ManNAc and pyruvate by the action of N-acetylneuraminate pyruvate lyase. [21] The key metabolite, pyruvate, can be used in the tricarboxylic acid (TCA) cycle or converted to lactate by lactated ehydrogenase (LDH). However,c ompared to the respective WT lines, neither intracellular nor secreted lactate levels were significantly altered in CMAS-deficient mESC or HEK 293 cells ( Figure 5B ,C ). Similarly, no genotype-related changes could be detected for the TCA cycle metabolites citrate,a conitate, a-ketoglutarate, succinate, malate and fumarate ( Figure 5D-I) .
We then investigated the intracellular O-GlcNAcylation outcome. This pathway was researched because we speculated that the elevated Sia levels might drive ManNAc epimerisation to GlcNAcb yt he action of GlcNAc-2-epimerase. GlcNAc in turn can be phosphorylated and activated to UDP-GlcNAc, which is furtherutilised for N-, O-a nd glucosaminoglycan (GAG) biosynthesis as well as intracellular O-GlcNAcylation ( Figure 5A ). In western blot analysiso fw hole-cell lysates by using the OGlcNAc specific CTD110.6 antibody, highly similar staining patterns (including band intensities) were observed between Cmas À/À and WT cells ( Figure 5J ), thus arguing against altered global O-GlcNacylation in Cmas-knockoutc ells. Thus, elevated cytosolicN eu5Acl evels influenced neither relatedm etabolite levels nor intracellular glycosylation.
Sialylation is dispensablef or differentiation into EBs and for onset of germ layer formation in mESCs
Next, we investigated at the transcriptome, protein and histologic levelsi fs ialoglycans are ap rerequisite for differentiation of mESCs towards the three germ lineages during undirected EB formation. In order to ensure uniform differentiation conditions, mESCsw ere seededi nahangingd rop culture, thus giving rise to one EB per drop and subsequent individual cul- tures thereof. We analysed the mRNA expression pattern of two undifferentiatedW Ta nd three Cmas À/À mESCs( time point 0, "LIF") and resultant EBs after 2, 4a nd 8d ays of differentiation. The global gene expression profile was subjected to principal component analysis( PCA;F igure 6A). This statistical procedure is av aluablet ool to compares amples with large amountso fd ata, as it converts the data into ac oordinate system,t hereby reducingt he dimensions of ad ataset of multiple samples without losing useful information.T he three principal components (PC1-3; x/y/z axes) cover 88 %o fthe variability in the whole data set obtainedf rom the five cell lines; thus giving av ery good overall impression of the analysed transcriptomes. The data points of the five undifferentiated mESC lines (LIF) are all very close together,t hus indicating Figure 3 . Loss of CMAS activity in mESCs entails increased exposure of galactose and oligo-LacNAcr esiduesa tt he cellsurface. The y-axis of normalised electropherogram is divided by the summed peak height of all quantifiable peaks (S/N ! 9);relativesignal intensity [%] of total peak heighti splotted. A) and C) Differentialx CGE-LIFa nalysisofN-glycans from undifferentiated Cmas + / + and Cmas À/À mESCs:electropherogram regions from A) 140 to 480 normalised migrationt ime units (MTU)a nd C) 400to6 50 MTU. B) Electropherogram of undifferentiated Cmas À/À mESCs before(black) and after sialidase treatment (red). N-Glycan structures in xCGE-LIFa nalyses are annotated:sialylated N-glycans (1-6), galactosec apped N-glycans( 7-10) and oligo-LAcNAc capped N-glycans (11) (12) (13) (14) (15) . Example N-glycan structures 1t o1 5a re depicted (right;d etailed N-glycan annotation in FigureS4). Activity andspecificity of A. urefaciens sialidase was confirmedb yt reatment of bovine fetuin and subsequent xCGE-LIF analysis of the well-defined N-glycans (FigureS3A). Structures are presentedf ollowing the Consortium for Functional Glycomics notation (www.functionalglycomics.org/glycomics/molecule/jsp/carbohydrate/carbMoleculeHome.jsp). Linkage positionso fsialicacids are indicated by differing angles. All mESC lines were culturedf eeder-free with LIF supplementation to maintainthe pluripotent state (Cmas ). During the time course the data pointsf ormed at ilted C-shaped pattern. This pattern is known from in vitrod ifferentiated human ESC lines, [22, 23] and indicates induction of developmental processes and ac ontinuous differentiation of all mESC lines independent of the genotype. In order to verifyc orrect exit from pluripotencya nd induction of germ layer formation, mRNAe xpression levels for selected pluripotency-and differentiation-related genes were compared ( Figure 6B-E) . The levels of the pluripotencym arkers (Oct3/4, Sox2,a nd Nanog) were similar in WT and Cmas À/À mESC lines at time zero, just as the changesd uringt he timecourseo fp luripotencye xit and up to day 8o fd ifferentiation ( Figure 6B ). At day 4, expression of mesodermal markerg enes closelyl inkedt og astrulation (brachyury,f ibroblast growth factor8 (Fgf8) and Wnt3;F igure 6C)p eaked and declined again at day 8. The embryonic ectodermal markers of early epiblast development fibroblast growth factor 5( Fgf5)a nd orthodenticle homeobox protein 2( Otx2)r ose at day 2a nd declined at day 8w ith as imilar patternf or all genotypes, thus indicating differentiation of the embryonic ectoderm( Figure 6D ). Formation of the endodermal germ layerw as monitored by expression of the definitive visceral endoderm markers forkheadb ox proteinA2( Foxa2) and Sox17 [24] ( Figure 6E ). Foxa2 and Sox17 mRNA expression was induceda td ay 4o fd ifferentiation with almost comparable intensity and time-course in Cmas + / + and Cmas À/À EBs. Thus, the mRNA expression patterns of endo-, ecto-and mesoderm-specific geness eems unimpaired in Cmas À/À EBs. In order to confirm germ-layer formation in vitro, EBs were fixed and paraffin embeddeda fter eight days of culture. WT EBs consist of an outer layero fp rimitive visceral endoderm surrounding an innerc ore of pluripotent cells.F urther differentiation and cavity formationo fW TE Bs reflects germlayer formation and building of the proamniotic cavity in vivo. Immunohistologicals taining of EB sections of all genotypes exhibited as imilar morphology,i ncluding cavityf ormation (Figure 6F) . The endodermal marker Disabled-2 was expressed in epithelial cells surrounding the EB and lining the internalc avities in WT and Cmas À/À EBs. Similarly,t he ectododermalm arker Nestin( an intermediate filament protein) was present in EBs of both genotypes. In order to monitor the progresso fm esodermald ifferentiation, expression of the cardiac muscle cell marker a-smooth muscle actin( a-SMA)w as investigated. a-SMA was expressedi na ll EBs at day 8a fter LIF deprivation, thus confirming formation of mesodermal cardiac progenitor cells.F urthermore, rhythmicp ulsing was observed in monolayer differentiation experimentso fW Ta nd Cmas À/À mESC after elevend ays of cultivation,t hus indicating the capability of WT and Cmas À/À ESCs to differentiate intof unctional cardiomyocytes (Supporting Movies S1 and S2). 
Discussion
The exposed terminal positiono fS ia on cell-surface glycans predisposes the sugar as an important signalling component in cellularc ommunication. [7] Severalp athologies caused by reduced synthesis of Sia and/or sialoglycoconjugates have been describedi nh umans and in animal model system. [4, 25, 26] Interestingly, mutations causingc omplete loss of Sia biosynthesis are not observedi nh umans and are embryonic-lethal in mice. [8] It thus seems to be ag eneral rule that loss of Sia interferes with development and viabilityo fv ertebrates. The mechanismsb yw hich Sia impactse mbryonicd evelopment and differentiation are not wellu nderstood, but are of increasing interest with regard to the application of ESCs in regenerative medicine. We used mESCsa sav aluablet ool to address this question.I nC MAS-depleted mESCsa nd HEK 293 cells, we observed complete loss of sialylation on glycoconjugates at the cell surface, with intracellular accumulation of free Neu5Ac. Significantly,t hese experiments provide the first proof that CMAS is the only enzymec apable of activating Sia in mammalian cells and confirm earlier data demonstratingt he role of CMP-Sia as af eedback inhibitor of GNE. [2] Our finding that intracellular Sia accumulationh as no obvious influence either on major metabolic routes or on globalOGlcNAcylation levels was unexpected.H owever, our data corroborate ar ecent investigation carried out with breast cancer cells, [27] in which CMASexpression in 231MFP cellswas reduced by shRNA. As in our study,c hanges in the levels of lactate or TCA-cycle metabolites were not identified. [27] Althoughm etabolic changesh ave been observed to exertamarkedi nfluence on gene regulation andd ifferentiation in mESCs, [28] intracellular Sia accumulation does not seem to be criticalf or pluripotency and differentiation in mESCs.
At the cell surface, terminal Sia is linked to galactose (Gal) or N-acetylgalactosamine (GalNAc) residues. Loss of Sia on Cmas À/À mESC was associated with an increasei nG al-and oligoLacNAc-capped glycans. The latter observation was also described for HL-60 cells (human promyelocytic leukemia) after treatment with the global sialyltransferase inhibitor 3F-NeuAc. [29] Hence, sialylationm ight serve as an end-point signal of glycosylationf or certain glycans; and, in the absence of the donors ubstrate CMP-Sia, LacNAc structuresg et steadily elongated, most likely due to the action of competing glycosyltransferases, for example, b1,4-galactosyl-and b1,3-N-acetylglucosaminyltransferases that add LacNAc repeats. Loss of Sia on glycoconjugates at the cell surface presumably hast wo consequences:i ta bolishes the binding of Sia-specific lectins,w hich could lead to loss of functiono f, for example, Siglecs;a nd it could readily be accompanied by ag ain in functiono fl ectins preferring neutralg lycans, for example, galectins. [30] Thus, it seems likely that cell-surface sialylation has an impact on pluripotencya nd/ord ifferentiation in mESCs, as recently reported for human ESC and iPSC lines. Reduction of a2,6-sialylationb y down-regulation of the sialyltransferase ST6GAL1 entails ad e- 
LDH). Quantification of B) intracellular and C) cell-culturelactate levels from WT and CMAS-deficient mESC and HEK metabolite extracts by HPLC-MS/MS (nmol per mg protein). D-I) Quantification of intracellular TCA cycle metabolite levels from WT and CMAS-depleted mESC and HEKmetabolite extracts by HPLC-MS/MS (pmol per mg protein). J) Analysisofg lobal O-GlcNAcylation.
Whole-cell lysates of WT and CMAS-deficient mESCand HEK cells were analysed by SDS-PAGE and western blottingwith mAb CTD110.6. Specificity of antibody staining was controlled by preincubation of the primary antibodywith N-Acetylglucosamine( GlcNAc). Anti-actin staining was used as loading control. All mESC lines were culturedf eeder-freewith LIF supplementation to maintainthe pluripotent state (Cmas + / + mESC n = 2, Cmas À/À mESC n = 3, for all HEK cell lines n = 3). Figure 6 . Loss of sialylation does not affect primary germ layer formation of mESCs in vitro. A) Principal component analysisoft ranscriptomic data from undifferentiated (LIF) mESC and after two, four and eight days of EB differentiationo fCmas + / + (green, n = 2) and Cmas À/À (red and purple, n = 3) mESCl ines.B)-E) mRNA expression quantifiedbyn ormalised fluorescence intensityo fB) pluripotency factors Oct3/4, Sox2a nd Nanog; C) mesodermal markersB rachyury, Fgf8 and Wnt3;D)embryonic ectodermal markersFgf5 and Otx2;and E) endodermal markers Foxa2 and Sox17 obtained from transcriptome array data.F )Indirect immunofluorescence and immuno-histochemicalanalysis of sections from paraffin-embedded Cmas + / + and Cmas À/À EBs after eight daysofd ifferentiation. The capacity to form primary germ layers was detected by staining for the marker proteins Disabled-2, Nestin and a-smooth muscle actin (a-SMA). crease in the mRNA expressiono fp luripotencyf actor Oct3/4 (POU5F1) in hPSCs,a nd impedes the induction of pluripotency in somatic cells. [12] Furthermore, neuraminidase treatment induced differentiation in human iPSCs derived from menstrual blood-derived mesenchymalc ells (iPS-MBMC) as well as of human embryonic stem cells(hESC),t hus suggesting that sialylation is involved in the maintenance of pluripotency. [31] In stark contrast, murine asialo Cmas À/À ESCs did not exhibit any change in gene expression of the pluripotency network, thus suggesting that the maintenanceo fp luripotency in murine ESCs is not dependento nc ell-surface sialylation. These divergent results (between human and murine ESCs) might be attributable to species-specific differences [32] as well as to alterations in the differentiation states of mESC and hiPSC/hESC. [33] Interestingly,i na nm ESC proteomic investigation, CMAS was identified as an interaction partnero ft he centralp luripotency factor Oct3/4. [34] However,a sw es how here, neither Oct3/4 mRNA expression level nor protein localisation was altered in Cmas À/À ,c ompared to WT mESC. In terms of differentiation capacity,d ifferent effects of cellsurfaces ialylation have been reported for murine and human ESCs. Although polySia is essential for endodermalg erm layer differentiation in hESCi nv itro, [35] mice with complete loss of polysialic acid are viable and fertile. [36] Analysis of hyposialylated GNE-deficient mESC in vitro also revealed ap robabler ole of sialylation in differentiation. [14] Although impairedi nd en ovo Sia synthesis, GNE-deficient mESCw ere able to retrieve free Sia by the lysosomal salvage pathway. [37] Hence, the sialylation status of GNE-deficient mESCs depends on the presence of sialoglycoconjugates and free Sia in the medium. Impaired differentiationa nd even the demise of EB from GNE-deficient mESCs was overcome by culturing the cells in mediumw ith high levels of Sia, thuss uggesting that sialylation has an impact on processes regulating embryonic differentiation in vitro. [14] In contrast, in Cmas À/À mESCst he exit from pluripotency and induction of differentiation into the three germ layers was not affected by sialylation. The observed discrepancy between Gne À/À and Cmas À/À mESCs might reflect differente ffects of hyposialo-and asialo-cell surfaces for signalling and/or cell-celli nteraction, respectively;o rt his might be attributable to geneticdifferences in the murinemodels. [38] Moreover,aregulatory function of GNE (independent of its enzymatic activity) has also been postulated recently and must be considered. [39] Strikingly,s ialylationi sd ispensable for ecto-, endo-and mesoderm formation:t he three germ layers formed in vitro (Figure 6F) , thusc onfirming the data obtained in the comparative transcriptome and differentiation marker analysis of Cmas
and Cmas À/À mESCs( as wella sd erived EBs). In fact, Cmas À/À mESCs gave rise to beating foci, thusc learly implying the capacity for cardiomyogenic differentiation. The data presented in this study leave no doubt that loss of CMAS (and the resulting sialylation capacity) has little if any impact on the early steps of murine ESC differentiation in vitro.
Sialylation is au biquitous, fundamentalp rocess in vertebrates, but it seems to be dispensable for pluripotency as well as for earlyd ifferentiation of mESC.A ss ialylation is ar elatively new "invention" in evolution, our data inspire the speculation that early developmental processes evolved in the absence of Sia and remained independento fs ialylation in embryogenesis, whereas Sia became pivotali nt he later stages of development. This idea is supported by the fact that in both human and mouse the degree of sialylation increases with differentiation, both in vitro and in vivo. [40] However,w ith the observed discrepancies between human andm urine ESCs, more data of sialylation-impaired animal modelsf rom different speciesa re requiredt of ully understand the role of sialic acid in an evolutionary context.
Experimental Section
Mice: Mouse strains were obtained from the animal facility (ZTL) of Hannover Medical School. In order to inactivate the Cmas gene, at argeting vector was constructed in which exon 4( encoding the active site of the protein) was flanked by loxP sites. An frt-flanked neomycin resistance gene (neo) for positive selection was inserted into intron 4, and ad iphtheria toxin gene for negative selection was inserted into intron 3. The entire vector was sequence-verified and introduced into E14-1 ESCs. Correct homologous integration of the construct was verified by PCR ( Figure 1A,B ) . As ingle integration event was confirmed by southern blot analysis. ES cells were injected into C57Bl/6J blastocysts. The neo cassette was deleted by crossing Cmas neo/neo mice with the Flp-deleter strain SJLTg(ACTFLPe)9205Dym/J. Resulting Cmas floxed mice were bred to homozygosity and crossed with the Cre-deleter strain C57BL/6-Tg(Zp3-cre)93Knw/J. Upon further backcrosses with Bl/6 mice, heterozygous Cmas knockout mice (Cmas + /À )w ere obtained. These animals were crossed to NMRI, and intercrosses of Cmas + /À animals gave rise to Cmas À/À embryos. The targeting vector and resulting Cmas alleles are shown in Figure 1A ; Cmas mutants and their genotyping by PCR is in Figure S1 (primers are available upon request). Animals were hosted in the ZTL of the Hannover Medical School under specific pathogen-free conditions. All animal experiments were carried out in compliance with German law for protection of animals and were approved by the local authorities (TV 33.12-42502-04-13/1312).
Cell culture: Generation of Cmas + / + , Cmas + /À and Cmas À/À murine embryonic stem cells (mESC) was performed as previously described. [41] In brief, E3.5 blastocysts from heterozygous Cmas + /À matings were cultured on irradiated murine embryonic fibroblasts (MEF) in high-glucose Dulbecco's modified Eagle'sm edium (DMEM, Biochrom, Cambridge, UK) supplemented with knockout serum replacement (KOSR, 15 %; Gibco), l-glutamine (2 mm; Biochrom), 2-mercaptoethanol (0.1 mm), leukaemia inhibitory factor (LIF,1 000 UmL À1 ;M erck Millipore), CHIR99021 (3 mm;k indly provided by Prof. Scheper,I nstitute of Te chnical Chemistry,L eibniz University,H annover) and PD0325901 (1 mm;S igma-Aldrich) at 37 8C under CO 2 (5 %). After 6t o9days, the outgrowth of the inner cell mass was enzymatically disaggregated and further cultivated on MEFs in mESC medium (medium as above but with foetal calf serum (FCS, 15 %; Biochrom) and without KOSR, CHIR99021 or PD0325901). All experiments were carried out in mESC medium; depletion of MEFs was accomplished by dilution of mESC for at least three passages. For EB formation, feeder-free pluripotent mESCs were trypsinised, counted and seeded on the lids of cellculture dishes (2000 cells, 25 mLp er drop of LIF-deprived mESC medium. After 48 h, homogenous EB formation was accomplished by transferring one EB per well to uncoated wells of 48-well dishes (agitation at 75 rpm). In order to analyse the capacity of mESCs to form beating foci, mESCs were cultured as am onolayer without MEFs and deprived of LIF for 11 days. The medium was changed every day,a nd the occurrence of beating foci was monitored by bright field microscopy.B eating foci containing monolayer cultures of differentiated mESC were used for western blot analysis of polysialic acid expression upon differentiation.
HEK 293 cells (kindly provided by the Institute of Cell Biology, Hannover Medical School) were cultivated at 37 8Cu nder CO 2 (5 %) in DMEM/Ham's F-12 medium (1:1;B iochrom) supplemented with FCS (10 %), l-glutamine (2 mm) and penicillin/streptomycin (100 UmL À1 ). Cells were passaged by rinsing with fresh medium. CHO cells [42] were similarly cultivated in medium supplemented with FCS (5 %) and sodium pyruvate (1 mm).C ells were passaged with trypsin (0.05 %)/EDTA( 0.02 %).
Generation of HEK 293 CMAS
À/À clones: HEK 293 CMAS À/À cells were generated by CRISPR/Cas9-mediated genome editing with ag uide RNA targeting residues 128 to 155 of CMAS exon 1( 5 '-GCAGC CCTAA TTCTG GCCCG-3'). The target sequence was cloned into plasmid pX330-U6-Chimeric_BB-CBh-hSpCas9 (Addgene plasmid 42230 akind gift from Feng Zhang). [43] Wild-type cells were cotransfected with plasmid pX330-U6-Chimeric_BB-CBh-hSpCas9-hCMASgRNA and av ector containing an eomycin or puromycin resistance gene. After 24 h, the cells were selected with G418 or puromycin for 4-5 days, and single-cell clones were obtained by limiting dilution. Clones were screened for insertions and deletion by PCR and sequencing of the products by using primers 5'-AGGAA GATGG ACTCG GTGG-3' and 5'-CCGGA TCTTG CACATC CCT-3'.S equence alignment and analysis were performed with SnapGene (GSL Biotech, Chicago, IL).
Western blotting: Cells were lysed in RIPAb uffer (supplemented with 1 mm PugNAc to analyze O-GlcNAcylation);p rotein concentration was determined by aB CA Assay (Thermo Fisher Scientific). Sialidase and endosialidase treatment was performed by incubation with either neuraminidase from Arthrobacter urefaciens (20 Ug À1 protein cell lysate;E YL aboratories, San Mateo, CA) or endoneuraminidase NF (4 mg g À1 protein cell lysate) for 1h at 37 8C. Endoneuraminidase NF was purified as reported earlier. [44] Protein (30 mg) was separated by 8o r1 2% SDS-PAGE, transferred to PVDF membrane (or nitrocellulose for analysis of O-GlcNAcylation) and incubated with primary antibody:i n-house made polyclonal rabbit anti-CMAS antibody S59 (1:10 000); [45] mouse anti-actin antibody (1:100 000, Merck Millipore);i n-house made mouse anti-PolySia antibody 735 (1:3000). [46] After incubation with either anti-rabbit HRPconjugated secondary antibody (1:15 000, Jackson ImmunoResearch Laboratories, West Grove, PA)o rH RP-conjugated goat antimouse secondary antibody (1:15 000, Southern Biotech, Birmingham, AL), detection was performed with enhanced chemiluminescence. Lectin analysis (MAA, PNA) were performed with aD IG glycan differentiation kit (Roche), according to the manufacturer's instructions and detected with HRP-conjugated anti-digoxigenein antibody (1:5000, Roche) and enhanced chemiluminescence. OGlcNAcylation was detected with antibody CTD110.6 (1:1.000, Cell Signaling) before and after preincubation with GlcNAc (0.1 m)a t 4 8Cf or 10 min and HRP-conjugated mouse-IgM secondary antibody (1:15.000, Jackson).
Indirect immunofluorescence and CtxB staining: Feeder-free mESCs were seeded onto gelatin-coated coverslips, and after two days of culture, were fixed with paraformaldehyde (4 %), permeabilised with Triton X-100 (0.2 %), blocked with BSA (1 %) in PBS (blocking solution) and incubated with mouse anti-Oct3/4 antibody (Santa Cruz Biotechnology) in blocking solution (1:50) for 1hat RT.
After three washes with PBS, Alexa Fluor 488-conjugated antimouse IgG2b (1:500;M olecular Probes) was applied in blocking solution (1 h, RT). For CTXB staining, fixed cells were incubated with FITC-conjugated CTXB (1:200 in blocking solution;S igma-Aldrich) for one hour.S amples were mounted in Vectashield (Vector Laboratories, Burlingame, CA) containing DAPI (to stain nuclei)a nd analysed with an AxioObserver.Z1 microscope (Zeiss) equipped with aZeiss AxioCam MRm digital camera and an ApoTome.
Quantitative PCR: RNA preparation, cDNA synthesis and quantitative PCR analysis were as previously descibed 46] with the exception that after TRIzol extraction, RNA was precipitated with isopropanol (500 mLp er mL TRIzol), and the resulting pellet was washed in ethanol (1 mL, 75 %, v/v), air dried and dissolved in RNAse-free water. The primers (Sigma-Aldrich) are listed in Table S1 .
Multiplexed capillary gel electrophoresis with laser-induced fluorescence detection (xCGE-LIF): Cells were lysed in RIPAb uffer (Tris (50 mm, pH 8) with NaCl (150 mm),N P-40 (1 %( v/v); Roche), sodium deoxycholate (0.5 %, w/v;S igma-Aldrich) and SDS (1 %, w/ v;S erva Heidelberg, Germany)) supplemented with HALTp rotease inhibitor (Thermo Fisher Scientific) by pipetting up and down af ew times followed by freezing at À80 8Co vernight. Thawed cells were sonicated two times for one minute, followed by centrifuging (13 000 g,1 5min, 4 8C). Proteins were precipitated with af ourfold excess of acetone at À20 8Co vernight. Further sample preparation and xCGE-LIF glycoanalysis was as previously described. [17] Briefly, protein pellets were fully dissolved in PBS containing SDS (2 %, w/ v)a nd incubated for 10 min at 60 8C, then remaining SDS was neutralised by adding IGEPAL (8 %; Sigma-Aldrich) in PBS. N-glycans were released from denatured and linearised plasma protein for 3h at 37 8Cb yaddition of peptide-N-glycosidase F( PNGase F; Sigma-Aldrich) in PBS. In order to obtain N-glycosylation patterns by xCGE-LIF,r eleased N-glycans were first labelled with 8-aminopyrene-1,3,6-trisulfonica cid (APTS;S igma-Aldrich), and excess label was removed by using ap olyacrylamide-based stationary phase in hydrophilic-interaction-chromatography (HILIC) mode. For this, Bio-Gel P10 (200 mL, 100 mg mL À ;B io-Rad) in MilliQ water/ethanol/acetonitrile (70:20:10, v/v/v)w as applied to each well of a0.45 mmGHP filter plate (Pall Corporation, New York, NY). The solvents were removed by using avacuum manifold (Merck Millipore). All wells were prewashed with MilliQ water (3 200 mL), followed by equilibration with acetonitrile (80 %, 3 200 mL). APTS-labelled samples were placed in wells containing Bio-Gel P10 suspension and shaken (500 rpm) for 5min to improve glycan binding. For purification, wells were washed with acetonitrile (80 %, 5 200 mL) containing triethylamine (100 mm; Sigma-Aldrich), adjusted to pH 8.5 with acetic acid (Sigma-Aldrich), then washed with acetonitrile (80 %, 3 200 mL) All washing steps were performed by addition of solution, incubation for 2min and removal of solvent by vacuum. For elution, Bio-Gel P10 (swollen size 100 mL) and MilliQ water (2 200 mL) were applied to each well followed by 5min incubation with shaking (500 rpm). The eluates were removed by vacuum and collected in a9 6-well storage plate (Thermo Fisher Scientific). The combined eluates were stored at À20 8C. Purified APTS-labelled N-glycans were separated by capillary gel electrophoresis and monitored by laser-induced fluorescence detection. glyXtool (glyXera, Magdeburg, Germany) was used for processing of xCGE-LIF data, and for normalisation of migration times to an internal standard. N-Glycan fingerprints were created from the electropherograms:s ignal intensity in relative fluorescence units (RFU) is plotted on the y-axis against normalised migration time units (MTU) on the x-axis. Because of the high reproducibility of normalised migration times, N-glycan fingerprints of different samples can be compared. N-glycan structural elucidation and peak annotation was made by using our in-house N-glycan database. For correct annotation of the glycans, several exoglycosidase digests (including chemical release of sialic acids by mild acid hydrolysis) were performed: Streptococcus pneumoniae a(2-3) sialidase (Prozyme, Hayward, CA), Clostridium perfringens a(2-3,6) sialidase (Prozyme), Arthrobacter ureafaciens a(2-3,6,8) sialidase (Prozyme), Xanthomonas a (1-3,4) fucosidase (QABio, San Mateo, USA), Xanthomonas manihotis a(1-2) fucosidase (New England Biolabs), bovine kidney a (1-2,3,4,6 ) fucosidase (Prozyme), X. manihotis b(1-3) galactosidase (New England Biolabs), Bacteroides fragilis b1-4) galactosidase (New England Biolabs), Jack bean b (1-4,6 ) galactosidase (Prozyme), green coffee bean a (1-3,4,6 ) galactosidase (Prozyme), Streptococcus pneumoniae b (1-2,3,4,6 )-N-acetylglucosaminidase (New England Biolabs), Jack bean a (1-2,3,6 ) mannosidase (Prozyme).
Neu5Ac quantification: Intracellular mESC metabolites were extracted from one confluent well of a1 2-well plate by using acetonitrile/methanol/water (2:2:1, v/v/v)a ss olvent. Samples were centrifuged (20 800 g,1 0min), and the supernatants were evaporated and dissolved in H 2 O. Protein concentration was determined baBCA assay (Thermo Fisher Scientific). Extraction of metabolites from medium (50 mL) after two days of culture was accomplished as described for intracellular metabolites with acetonitrile/methanol (1:1) as extraction solvent. Free sialic acids were derivatised with DMB (as described by Hara et al.) . [48] Briefly,S ia was labelled for 2.5 ha t5 08Cw ith DMB (8 mm; Dojindo Laboratories, Kumamoto, Japan) in propionic acid (1.5 m) containing 2-mercaptoethanol (0.8 m) and sodium hydrosulfite (14.2 mm).D MB-derivatised Sia was separated by using aP rominence CBM-20A UFLC system (Shimadzu) equipped with aX Select CSH C18 reversed-phase HPLC column (4.6 mm 250 mm, 5.0 mm particle size;W aters). Isocratic elution was performed with acetonitrile/methanol/H 2 O( 9:7:84, v/v/ v)a taflow rate of 0.3 mL min À1 ,a nd fluorescence was monitored with aR F-10A XL fluorescence detector (excitation 372 nm, emission 456 nm;S himadzu). For the assignment of individual peaks, the DMB-labelled Glyko Sialic Acid Reference Panel (Prozyme) or DMB-derivatised bovine submaxillary mucin (Sigma-Aldrich) was used.
Metabolite analysis: Intracellular and medium metabolites were extracted as described for Neu5Ac quantification. For HPLC-MS/MS analysis aS IL-HTcl iquid chromatography system (Shimadzu) with an inserted guard column and aK inetex C 18 column (Phenomenex) was coupled to an API4000 triple quadrupole mass spectrometer (Sciex, Framingham, MA) with electrospray ionisation, operated in negative ionisation mode. An isocratic gradient (water/methanol (97:3, v/v)containing formic acid (0.2 %)) was applied for chromatographic separation. Metabolite identification was done using multiple reaction monitoring with two mass transitions per analyte, of which one was used as quantifier.A ni nternal standard ( 13 C 2 -citrate, Sigma-Aldrich) was added during the extraction procedure to each sample, and ac alibration curve with customised standard substances ([ 13 C 2 ]2,4-citrate:4 92078, citrate:2 51275, lactate:7 1718, cisaconitate:A 3412, a-ketoglutarate:7 5892, succinate:W 327700, malate:1 12577, fumarate:F 1506;S igma-Aldrich) at appropriate concentrations was applied for quantitation.
Immuno-histochemistry: After eight days of differentiation, EBs were harvested, washed once in ice cold PBS and fixed in paraformaldehyde (4 %, v/v). Subsequently,E Bs were washed again in PBS (30 min) and dehydrated by ag raded ethanol series with subsequent paraffination. Paraffinised EBs were sliced into 3 mms ections with an RM 2265 microtome (Leica) and rehydrated. Sections were subsequently heated at 95 8Cf or 10 min in Ta rget Retrieval Solution (Dako/Agilent Te chnologies), blocked with either BSA (1 %) or non-fat dry milk (5 %) in PBS (blocking solution) and subsequently incubated with primary antibody in blocking solution over night at 4 8C: mouse anti-Disabled-2 (1:200, BD Transduction Laboratories), mouse anti-actin a-smooth muscle (Sigma-Aldrich), rabbit antiNestin (1:100, Abcam). Secondary antibodies were either Alexa Fluor 555-conjugated anti-mouse IgG (Molecular Probes), visualised by fluorescence microscopy as described earlier,o rH RP-coupled anti-rabbit IgG (Jackson ImmunoResearch) visualised by using DAB + chromogen (Dako). Nucei were counterstained with vectashield or hematoxylin, respectively.I maging was performed in an AxioObserver.Z1 microscope equipped with an AxioCam Mrm camera for fluorescence, or an AxioCam Mrc camera for bright-field pictures of DAB-stained tissue.
Transcriptomics: RNA was prepared by the Trizol method from pluripotent mESCs cultivated under feeder-free conditions with LIF supplementation, as well as from EBs after 2, 4a nd 8days of differentiation. To tal RNA (396 ng) was used for the synthesis of aminoallyl-UTP-modified (aaUTP) cRNA with the Quick Amp Labeling kit, No Dye (Agilent Te chnologies) according to the manufacturer's recommendations with ATP, CTP,G TP (2.5 mm each) and UTP,a aUTP (1.25 mm each) by the use of NTP Set and aminoallyl-UTP (Thermo Fisher Scientific). aaUTP-cRNA was labelled with Alexa Fluor 555 Reactive Dye (Life Te chnologies) as described in the Amino Allyl MessageAmp II Kit Manual (Life Te chnologies). Prior to the reverse transcription reaction, One-Color Spike-In Kit solution (0.5 mLo f a1 :1000 stock;A gilent Te chnologies) was added to each of RNA sample (396 ng). Fluorescently labelled cRNA populations (500 ng each) were used for fragmentation, hybridisation and washing steps, as recommended in the One-Color Microarray-Based Gene Expression Analysis Protocol V5.7 (Agilent Te chnologies). Slides were scanned on aG 2565CA Microarray Scanner (pixel resolution 3 mm, bit depth 20;A gilent Technologies) at the Research Core Unit Metabolomics at Hannover Medical School. Data extraction was performed with Feature Extraction Software V10.7.3.1 (Agilent Te chnologies) by using the extraction protocol file "GE1_107_ Sep09.xml", except that the Multiplicative detrending algorithm was inactivated. Statistical analyses were carried out in Qlucore Omics explorer (Scheelevägen, Sweden). A p value of 0.05 and a q value of 0.05 were applied to multi-group comparisons between control and CMAS-negative mESC and EBs in order to identify differentially expressed genes. Keywords: CMP-sialic acid synthase · differentiation · glycosylation · metabolism · sialic acids
